RELATIVE IMMUNOGENICITY IN MICE OF WHOLE AND SPLIT INFLUENZA-VIRUS

[1] INACTIVATED INFLUENZA VACCINE EFFICACY - DIMINISHED ANTIGENICITY OF SPLIT-PRODUCT VACCINES IN MICE [J]. INFECTION AND IMMUNITY, 1974, 10 (06) : 1329 - 1336

[2] COMPARATIVE TRIAL OF INFLUENZA VACCINES .1. IMMUNOGENICITY OF WHOLE VIRUS AND SPLIT PRODUCT VACCINES IN MAN [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1976, 104 (01) : 34 - 46

[3] CRYSTALLINE ANTIGEN FROM INFLUENZA-VIRUS ENVELOPE [J]. NATURE-NEW BIOLOGY, 1972, 238 (83): : 145 - &

[4] DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5

[5] DAVENPORT FM, 1968, P SOC EXP BIOL MED, V127, P587

[6] HOWARD JG, 1971, IMMUNOLOGY, V21, P535

[7] ISAACS A, 1951, BRIT J EXP PATHOL, V32, P325

[8] NEURATH AR, 1970, MICROBIOS, V2, P209

[9] NEURATH AR, 1971, MONOGRAPHS VIROLOGY, V4

[10] PALMER DF, 1975, IMMUNOLOGY 6

[1] INACTIVATED INFLUENZA VACCINE EFFICACY - DIMINISHED ANTIGENICITY OF SPLIT-PRODUCT VACCINES IN MICE [J]. INFECTION AND IMMUNITY, 1974, 10 (06) : 1329 - 1336

[2] COMPARATIVE TRIAL OF INFLUENZA VACCINES .1. IMMUNOGENICITY OF WHOLE VIRUS AND SPLIT PRODUCT VACCINES IN MAN [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1976, 104 (01) : 34 - 46

[3] CRYSTALLINE ANTIGEN FROM INFLUENZA-VIRUS ENVELOPE [J]. NATURE-NEW BIOLOGY, 1972, 238 (83): : 145 - &

[4] DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5

[5] DAVENPORT FM, 1968, P SOC EXP BIOL MED, V127, P587

[6] HOWARD JG, 1971, IMMUNOLOGY, V21, P535

[7] ISAACS A, 1951, BRIT J EXP PATHOL, V32, P325

[8] NEURATH AR, 1970, MICROBIOS, V2, P209

[9] NEURATH AR, 1971, MONOGRAPHS VIROLOGY, V4

[10] PALMER DF, 1975, IMMUNOLOGY 6